Papers of the Week

Buprenorphine is effective for the treatment of opioid use disorder and chronic pain, has a safer pharmacological profile than full-mu opioid agonists, and can now be prescribed by any U.S. provider with a DEA license. Our study purpose was to examine a decade of buprenorphine prescribing patterns in the U.S.